from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3840/-

LFCtreatmentdescriptionclass of inhibitor

-0.429

Amikacinug/mL Amikacintranslation

0.000

Cap5-10ug/mL Capreomycintranslation

-0.088

Rox10-50 ug/mL Roxithromycintranslation

-0.173

SM2-5 ug/mL Streptomycintranslation

-0.257

Tet5-10 ug/mL Tetracyclinetranslation

-0.739

Rif0.2-5ug/mL Rifampicintranscription

-0.618

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.794

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.960

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.129

CPZ10-50 ug/mL Chlorpromazinerespiration

2.918

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.161

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.264

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.446

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.433

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.202

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.474

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.326

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.184

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.089

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.076

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.378

Nigericin50 uM Nigericinrespiration

-0.636

TRC10-150 ug/mL Triclosanrespiration

0.014

TRZ10-25 ug/mL Thioridazinerespiration

1.315

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.111

menadione6-10 ug/mL Menadionerespiration

2.263

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.990

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

2.398

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.644

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.418

NRP_1Non-replicating persistence stage 1dosRassociated

-0.032

Amp0.2mg/mL AmpicillincellWall

-0.187

Cephalexin20-100 ug/mL CephalexincellWall

-0.098

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.345

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.097

EMB10-20 ug/mL EthambutolcellWall

-0.113

Eta12-40 ug/mL EthionamidecellWall

-0.131

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.219

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.224

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.046

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.297

BZA0.12 mg/mL BenzamidearomaticAmides

-0.203

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.149

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.390

H2O24 mM hydrogen peroxideDNAdamaging

-0.248

Levo10 ug/mL LevofloxacinDNAdamaging

-0.050

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.367

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.147

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.157

UVUV-irradiationDNAdamaging

0.674

ARP41-4 ug/mL Antitubercular compound ARP4?

0.079

Antimycin12.5-50 ug/mL Antimycin A?

0.185

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.243

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.525

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.782

PA8240.2-2 ug/mL PA-824?

-0.981

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.676

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.294

Verapamil50 uM Verapamil?

-0.165

mercaptoethanol2 mM 2-Mercaptoethanol?

0.035

methoxatin10-20 ug/mL Methoxatin?